Hiroyuki Terawaki

Prof. Hiroyuki Terawaki

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in Kidney International
Verified
Journal Article
Closed access
PDF file
HTHiroyuki Terawaki
Hiroyuki Terawaki
KYKazunobu Yoshimura
Kazunobu Yoshimura
THToshio Hasegawa
Toshio Hasegawa
YMYukie Matsuyama
Yukie Matsuyama
TNTsuneo Negawa
Tsuneo Negawa
SESeiichi Era
Seiichi Era

6 July 2010 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
HTHiroyuki Terawaki
Hiroyuki Terawaki
YTYukie Takada
Yukie Takada
SESeiichi Era
Seiichi Era
YFYoichi Funakoshi
Yoichi Funakoshi
KNKeisuke Nakayama
Keisuke Nakayama
THTatsuo Hosoya
Tatsuo Hosoya

2 July 2011 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
MKMasatoshi Kawashima
Masatoshi Kawashima
KWKoji Wada
Koji Wada
HOHiroshi Ohta
Hiroshi Ohta
HTHiroyuki Terawaki
Hiroyuki Terawaki
YAYoshiharu Aizawa
Yoshiharu Aizawa
Background: Hyperuricemia is prevalent in patients with chronic kidney disease (CKD). We explored the hypothesis that asymptmatic hyperuricemia may be associated with new-onset CKD.Methods: The participants were all male factory workers in Kanagawa, Japan (n = 1,285). All were over 40 years of age and had undergone annual health examinations from 1990 to 2007. Individuals with a history of gouty attacks were excluded from the study. A retrospective cohort study was conducted by following the estimated glomerular filtration rate (eGFR) for each participant over a maximum period of 18 years. The endpoint was new-onset CKD defined as eGFR < 60 mL/min/1.73 m2. The associations between new-onset CKD and the presence of hyperuricemia, low serum high-density lipoprotein cholesterol, hypertension, diabetes, and obesity were analyzed.Results: The mean (± standard deviation) follow-up period was 95.2 (± 66.7) months, and new-onset CKD was observed in 100 participants (7.8%) during this follow-up. Cox proportional hazards model revealed that the hazard ratio of new-onset CKD due to hyperuricemia, low serum high-density lipoprotein cholesterol, hypertension and obesity were 3.99 (95% confidence interval: 2.59-6.15), 1.69 (1.00-2.86), 2.00 (1.29-3.11) and 1.35 (0.87-2.10), respectively. Concerning hyperuricemia, low serum high-density lipoprotein cholesterol, hypertension and obesity, the log-rank tests showedPvalues of < 0.01, 0.01, < 0.01 and < 0.01, respectively.Conclusion: The results of this study suggest that asymptomatic hyperuricemia is a predictive factor for new-onset CKD for Japanese male workers.

24 March 2010 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
HTHiroyuki Terawaki
Hiroyuki Terawaki
KYKeitaro Yokoyama
Keitaro Yokoyama
YYYukiko Yamada
Yukiko Yamada
YMYukio Maruyama
Yukio Maruyama
RIRinako Iida
Rinako Iida
THTatsuo Hosoya
Tatsuo Hosoya

1 January 2008 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
HTHiroyuki Terawaki
Hiroyuki Terawaki
HMHirohito Metoki
Hirohito Metoki
MNMasaaki Nakayama
Masaaki Nakayama
TOTakayoshi Ohkubo
Takayoshi Ohkubo
MKMasahiro Kikuya
Masahiro Kikuya
YIYutaka Imai
Yutaka Imai
Both chronic kidney disease (CKD) and masked hypertension (MHT) are known to be linked with an increased risk of cardiovascular disease (CVD), but their relationship has remained unclear. The present study aimed to evaluate the CKD incidence in individuals with MHT in the general Japanese population. We recorded self-measured blood pressure at home (HBP) and casual blood pressure (CBP) in 1,365 individuals (mean 63.0 years old; males, 32.5%; mean creatinine clearance [CCr], 60.9 mL/min; positive proteinuria, 6.7%) and classified the subjects into four groups: sustained normal blood pressure (SNBP, 60.3%), white-coat hypertension (WCHT, 14.9%), MHT (12.8%), and sustained hypertension (SHT, 12.0%). Kidney parameter results for the respective groups (SNBP, WCHT, MHT, and SHT) were as follows: 61.7 mL/min, 61.8 mL/min, 59.6 mL/min, and 57.3 mL/min for CCr, 4.2%, 8.9%, 10.3%, and 12.8% for the prevalence of positive proteinuria, and 2.3%, 3.0%, 6.3%, and 9.8% for the proportion with CCr<60 mL/min with proteinuria. Compared with the SNBP group, the MHT and SHT groups exhibited significant differences in these parameters (p<0.05, for each). The adjusted odds ratios for CCr<60 mL/min with proteinuria were significantly higher in the MHT (2.56) and SHT (3.60) groups compared with the SNBP group (reference). MHT, like SHT, is closely related to CKD, and HBP measurement could be a useful screening strategy to detect CKD in the general population.

8 June 2012 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
MOMakoto Ogura
Makoto Ogura
AKAi Kimura
Ai Kimura
KTKoki Takane
Koki Takane
MNMasatsugu Nakao
Masatsugu Nakao
AHAkihiko Hamaguchi
Akihiko Hamaguchi
THTatsuo Hosoya
Tatsuo Hosoya
Background: High salt intake in patients with chronic kidney disease (CKD) may cause high blood pressure and increased albuminuria. Although, the estimation of salt intake is essential, there are no easy methods to estimate real salt intake. Methods: Salt intake was assessed by determining urinary sodium excretion from the collected urine samples. Estimation of salt intake by spot urine was calculated by Tanaka’s formula. The correlation between estimated and measured sodium excretion was evaluated by Pearson´s correlation coefficients. Performance of equation was estimated by median bias, interquartile range (IQR), proportion of estimates within 30% deviation of measured sodium excretion (P30) and root mean square error (RMSE).The sensitivity and specificity of estimated against measured sodium excretion were separately assessed by receiver-operating characteristic (ROC) curves. Results: A total of 334 urine samples from 96 patients were examined. Mean age was 58 ± 16 years, and estimated glomerular filtration rate (eGFR) was 53 ± 27 mL/min. Among these patients, 35 had CKD stage 1 or 2, 39 had stage 3, and 22 had stage 4 or 5. Estimated sodium excretion significantly correlated with measured sodium excretion (R = 0.52, P < 0.01). There was apparent correlation in patients with eGFR <30 mL/min (R = 0.60, P < 0.01). Moreover, IQR was lower and P30 was higher in patients with eGFR < 30 mL/min. Estimated sodium excretion had high accuracy to predict measured sodium excretion, especially when the cut-off point was >170 mEq/day (AUC 0.835). Conclusions: The present study demonstrated that spot urine can be used to estimate sodium excretion, especially in patients with low eGFR.